HB 2022 - DIGEST

     Declares that "therapeutic substitution" means the dispensing of a therapeutic alternative or preferred drug instead of the original drug product prescribed, in accordance with either established written therapeutic interchange guidelines or protocols from the prescriber for the pharmacist to follow or as a result of a patient-specific consultation between the pharmacist and the prescriber.

     Provides that the medical assistance administration shall not restrict access to prescription medication through use of therapeutic substitution or other similar programs.